Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity [clinicaltrials:NCT00003548]
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity [clinicaltrials:NCT00003548]
Bio2RDF identifier
NCT00003548
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003548
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... cer of the peritoneal cavity.
brief title [clinicaltrials_vocabulary:brief-title]
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... study within 18
months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2000-05-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
advanced adult primary liver cancer
carcinoma of the appendix
fallopian tube cancer
metastatic gastrointestinal carcinoid tumor
recurrent adult primary liver cancer
recurrent anal cancer
recurrent breast cancer
recurrent carcinoma of unknown primary
recurrent cervical cancer
recurrent colon cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-03-25T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003548
official title [clinicaltrials_vocabulary:official-title]
Phase I Study of Intraperitone ...... fined to the Peritoneal Cavity
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000066605
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2001-12-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
U01CA076642
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-08-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-03-01T00:00:00Z
identifier
clinicaltrials:NCT00003548
title
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
@en
type
label
Aminocamptothecin in Treating ...... y [clinicaltrials:NCT00003548]
@en